MarketScreener Homepage > News > Sectors > Healthcare

News : Sectors

GLAXOSMITHKLINE PLC

Merck KGaA, GSK suffer lung cancer drug setback

ASTRAZENECA PLC

India, 'pharmacy of the world', starts COVID vaccine shipments to neighbours

BAYER AG

Bayer aims to help CureVac with COVID-19 vaccine output, says CEO

02:21p	35.9 MLN DOSES OF COVID-19 VACCINES DISTRIBUTED, 16.5 MLN ADMINISTERED : U.s. cdc	RE
02:01p	TAKEDA PHARMACEUTICAL : Brazil antitrust regulator clears hurdle for Hypera-Takeda deal	RE
11:57a	MERCK KGAA : Credit Suisse gives a Buy rating	MD
11:56a	Three COVID-19 vaccines under final review for emergency use - WHO	RE
11:51a	GLAXOSMITHKLINE : Goldman Sachs maintains a Buy rating	MD
11:50a	MERCK KGAA : Sell rating from Goldman Sachs	MD
11:17a	MERCK : Shares Fall After Announcement of Cancer-Drug Trial Interruption	DJ
11:13a	MERCK KGAA : Receives a Buy rating from JP Morgan	MD
10:51a	UNITEDHEALTH : Profit Slips as Health-Care Visits Return--Update	DJ
10:39a	Merck KGaA, GSK suffer lung cancer drug setback	RE
09:03a	ASTRAZENECA : India, 'pharmacy of the world', starts COVID vaccine shipments to neighbours	RE
08:53a	CARL ZEISS MEDITEC AG : Berenberg sticks Neutral	MD
07:50a	PRESS RELEASE : Pfizer and BioNTech Publish -3-	DJ
07:50a	PRESS RELEASE : Pfizer and BioNTech Publish -2-	DJ
07:50a	PRESS RELEASE : Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture	DJ

The best opportunities.
All the markets. Each month. In one click.

Discover

07:36a	BRISTOL MYERS SQUIBB : Gets FDA Priority Review for Two Opdivo Indications	DJ
07:33a	MERCK : Gets FDA Approval for Verquvo	DJ
07:32a	MERCK : stops lung cancer trial testing drug hopeful bintrafusp alfa	RE
07:28a	UNITEDHEALTH : Profit Slips as Health-Care Visits Return	DJ
07:11a	BAYER : Gets FDA Approval for Heart-Failure Drug Vericiguat	DJ
07:03a	GLAXOSMITHKLINE : UBS gives a Neutral rating	MD
06:40a	UNITEDHEALTH : 4Q Profit Falls as More Care Returns	DJ
06:27a	SIEMENS HEALTHINEERS : Berenberg gives a Buy rating	MD
06:21a	Russia files Sputnik V vaccine registration in Europe	RE
06:18a	CARL ZEISS MEDITEC AG : Deutsche Bank reiterates its Buy rating	MD
06:11a	PHILIPS NV : Berenberg reaffirms its Buy rating	MD
06:06a	MERCK KGAA : Buy rating from Credit Suisse	MD
06:03a	BAYER AG : Credit Suisse sticks Neutral	MD
06:01a	ASTRAZENECA : Receives a Buy rating from Credit Suisse	MD
06:01a	SANOFI : Credit Suisse reaffirms its Buy rating	MD
05:59a	ROCHE HOLDINGS AG : Credit Suisse sticks Neutral	MD
05:59a	NOVARTIS AG : Credit Suisse reiterates its Neutral rating	MD
05:45a	ASTRAZENECA : Oxford-AstraZeneca's Covid-19 Vaccine Helps U.K. Lead Race to Reach Nursing Homes	DJ
05:31a	Pfizer vaccine appears effective against coronavirus variant found in Britain -study	RE
04:52a	NOVO NORDISK : Credit Suisse gives a Neutral rating	MD
04:50a	GLAXOSMITHKLINE : Downgraded to Sell by Credit Suisse	MD
04:13a	China's COVID-19 vaccine makers apply to join COVAX scheme	RE
02:51a	NOVARTIS AG : Jefferies keeps its Buy rating	MD
02:34a	ASTRAZENECA : Gets EU Approval for Breast Cancer Treatment	DJ
02:28a	NOVO NORDISK : Jefferies remains a Sell rating	MD
02:26a	COVID-19 vaccine shots add to confusion over China's tests for travellers	RE
02:26a	ROCHE HOLDINGS AG : Jefferies maintains a Buy rating	MD
02:24a	GLAXOSMITHKLINE : Jefferies remains its Buy rating	MD
02:21a	SANOFI : Gets a Buy rating from Jefferies	MD
02:04a	ASTRAZENECA : Jefferies sticks Neutral	MD
02:00a	COVID-19 shots to cost $3 to $10 under African Union vaccine plan	RE
01:02a	EQS-NEWS : Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil	DJ
01:00a	MODERNA : CDC says 15.7 mln doses of COVID-19 vaccines administered in United States	RE
12:57a	Australian shares at near 11-month high as Yellen backs more U.S. stimulus	RE
01/19	NOVAVAX : S.Korea may secure additional COVID-19 vaccines from Novavax, Moon says	RE
01/19	Brazil battles Chinese red tape to get active vaccine ingredients	RE
01/19	U.S. exceeds 400,000 coronavirus deaths	RE
01/19	DGAP-PVR : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	DJ
01/19	U.S. exceeds 400,000 coronavirus deaths	RE
01/19	ASTRAZENECA : India to start COVID vaccine exports on Wednesday	RE
01/19	ASTRAZENECA : India to start COVID vaccine exports on Wednesday	RE
01/19	MODERNA : says possible allergic reactions to COVID-19 vaccine under investigation	RE
01/19	MODERNA : receives report of COVID-19 vaccine adverse events in San Diego	RE
01/19	Gilead Sciences Up Nearly 7%, Best Performer in the Nasdaq 100 So Far Today -- Data Talk	DJ
01/19	Brussels targets vaccinating at least 70% of EU adults by summer	RE
01/19	DGAP-DD : Fresenius SE & Co. KGaA english	DJ
01/19	GILEAD SCIENCES : U.S. Supreme Court rebuffs Merck appeal in hepatitis C patent fight with Gilead	RE
01/19	GILEAD SCIENCES : U.S. Supreme Court rebuffs Merck appeal in hepatitis C patent fight with Gilead	RE
01/19	MODERNA : New York governor asks Pfizer to directly sell COVID-19 vaccine doses	RE
01/19	THERMO FISHER SCIENTIFIC : Scooping Up Molecular-Diagnostic Firm	DJ

The best opportunities.
All the markets. Each month. In one click.

Discover

01/19	SANOFI : Gets a Buy rating from UBS	MD
01/19	Sputnik-AstraZeneca vaccine trials to start in February, says R-Pharm	RE
01/19	Philippines to buy 20 million Moderna vaccine doses as COVID-19 cases rise	RE
01/19	EVOTEC : Deutsche Bank revises his opinion and turns to Neutral	MD
01/19	NOVARTIS AG : JP Morgan reaffirms its Sell rating	MD

1 2 3 4 5 6 7 8 9 10 Next

MOST READ NEWS

1	NETFLIX, INC. : NETFLIX : forecasts an end to borrowing binge, shares surge
2	Alibaba's Jack Ma makes first public appearance in three months
3	RENAULT : Mercedes unveils electric compact SUV in bid to outdo Tesla
4	'Act big' now to save economy, worry about debt later, Yellen says in Treasury testimony
5	REFILE-ANALYSIS-A lot of hot air? Investors snap up hydrogen stocks in green frenzy